Status:
UNKNOWN
MS Relapses During COVID-19 Pandemic
Lead Sponsor:
Nottingham University Hospitals NHS Trust
Conditions:
Multiple Sclerosis
Covid19
Eligibility:
All Genders
16+ years
Brief Summary
Throughout the COVID-19 pandemic, and to our knowledge there have been no studies looking systematically at the occurrence of MS relapses and their subsequent management, during the peak of the first ...
Detailed Description
Multiple Sclerosis (MS) is a chronic inflammatory, demyelinating and neurodegenerative condition of the central nervous system (CNS) and is considered the most common cause of disability in young adul...
Eligibility Criteria
Inclusion
- Patients with a confirmed diagnosis of MS or Clinically Isolated Syndrome (CIS) and
- Atleast one clinician confirmed probable relapse between 01/04/2020 and 30/06/2020 or 01/04/2019 and 30/06/2019
Exclusion
- Age \<16 years
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT04858763
Start Date
May 1 2021
End Date
December 1 2021
Last Update
April 26 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.